Altered transcription and expression of PTEN in breast tumors: Is it regulated by hypermethylation?

Breast Disease

Volumn 33, Issue 1, 2011, Pages 27-33

  Shetty, Preetha J ^a,b   Pasupuleti, Nagarjuna ^c   Chava, Srinivas ^d   Nasaruddin, Khaja ^e   Hasan, Qurratulain ^a,b,c,d  

^a KAMINENI HOSPITALS   (India)

^b Vasavi Medical and Research Centre ^*  (India)

^c Kamineni Life Sciences   (India)

^d Bhagwan Mahavir Medical Research Centre   (India)

^e CNR Complex   (India)

Author keywords

Altered expression; breast cancer; CpG cluster; MSRA; promoter hypermethylation; PTEN

Indexed keywords

FORMALDEHYDE; PARAFFIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GENETICS; CANCER GROWTH; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; GERMLINE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METHYLATION SENSITIVE RESTRICTION ASSAY; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PTEN GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84858220893     PISSN: 08886008     EISSN: 15581551     Source Type: Journal    
DOI: 10.3233/BD-2010-0312     Document Type: Article

References (46)

1. Q.L. Okonkwo, G. Draisma, A. der Kinderen, M.L. Brown, and H.J. de Koning, Breast Cancer Screening Policies in Developing Countries: A Cost-effectiveness Analysis for India, J Natl Cancer Inst 100 (2008), 1290-1300.
2. T. Key, P. Verkasalo and E. Banks, Epidemiology of breast cancer, The Lancet Oncology 2(3) (2001), 133-140. (Pubitemid 33585924)
3. E.B. Claus, J.M. Schildkraut, W.D. Thompson and N.J. Risch, The genetic attributable risk of breast and ovarian cancer, Cancer 77 (1996), 2318-2324. (Pubitemid 26162426)
4. D.F. Easton, D.T. Bishop, D. Ford and G.P. Crockford, Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The breast cancer linkage consortium, Am J Hum Genet 52(4) (1993), 678-701. (Pubitemid 23310135)
5. J.P. Struewing, R.E. Tarone, L.C. Brody, F.P. Li and J.D. Boice, BRCA1 mutations in young women with breast cancer, Lancet 347(9013) (1996), 1493. (Pubitemid 26161232)
6. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie et al., PTEN a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer, Science 275 (1997), 1943-1947. (Pubitemid 27148818)
7. P.A. Steck, M.A. Pershouse, S.A., Jasser, W.K. Yung, H. Lin, A.H. Ligon, L.A. Langford, M.L. Baumgard, T. Hattier, T. Davis, C. Frye, R. Hu, B. Swedlund, D.H. Teng and S.V. Tavtigian, Identi.cation of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers, Nat Genet 15 (1997), 356-362. (Pubitemid 27147102)
8. W. Shi, X. Zhang, M. Pintilie, N. Ma, N. Miller, D. Banerjee, M.S. Tsao, T. Mak, A. Fyles and F.F. Liu, Dysregulated PTEN-PKB and negative receptor status in human breast cancer, Int J Cancer 104 (2003), 195-203. (Pubitemid 36249795)
9. H.E. Feilotter, V. Coulon, J.L. McVeigh, A.H. Boag, F. Dorion-Bonnet, B. Duboué, W.C.W. Latham, C. Eng, L.M. Mulligan and M. Longy, Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma, British Journal of Cancer 79(5/6) (1999), 718-723. (Pubitemid 29082095)
10. J. Reifenberger, M. Wolter, J. Bostrom et al., Allelic losses on chromosome arm 1q and mutation of the PTEN (MMAC1) tumor suppressor gene in primary and metastatic malignant melanomas, Virchows Arch 436 (2000), 248-293.
11. B.K. Rasheed, T.T. Stenzel, R.E. McLendon, R. Parsons, A.H. Friedman, H.S. Friedman, D.D. Bigner and H.H. Bign-er, PTEN gene mutations are seen in high-grade but not in low-grade gliomas, Cancer Res 57 (1997), 4187-4190. (Pubitemid 27413420)
12. M. Mikhail, E. Velazquez, R. Shapiro, R. Berman, A. Pavlick, L. Sorhaindo, J. Spira, C. Mir, K.S. Panageas, D. Polsky and I. Osman, PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation, Clin Cancer Res 11 (2005), 5153-5157. (Pubitemid 41003700)
13. Y.J. Yao, X.L. Ping, H. Zhang, F.F. Chen, P.K. Lee, H. Ah-san, C.J. Chen, P.H. Lee, M. Peacocke, R.M. Santella and H.C. Tsou, PTEN/MMAC1 mutations in hepatocellular carcinomas, Oncogene 18 (1999), 3181-3185. (Pubitemid 29261240)
14. P. Bruni, A. Boccia, G. Baldassarre, F. Trapassom, M. Santoro, G. Chiappetta, A. Fusco and G. Viglietto, PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1, Oncogene 19 (2000), 3146-3155. (Pubitemid 30455926)
15. H. Tashiro, M.S. Blazes, R. Wu, K.R. Cho, S. Bose, S.I. Wang, J. Li, R. Parsons and L.H. Ellenson, Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies, Cancer Res 57 (1997), 3935-3940. (Pubitemid 27427679)
16. A. Sakai, C. Thieblemont, A. Wellmann, E.S. Jaffe and M. Raffeld, PTEN gene alterations in lymphoid neoplasms, Blood 92 (1998), 3410-3415. (Pubitemid 28492352)
17. S. Bose, A. Crane, H. Hibshoosh, M. Mansukhani, L. Sandweis and R. Parsons, Reduced expression of PTEN cor-relates with breast cancer progression, Hum Pathol 33 (2002), 405-409. (Pubitemid 34627590)
18. A. Perren, L.P. Weng, A.H. Boag, U. Ziebold, K. Thakore, P.L. Dahia, P. Komminoth, J.A. Lees, L.M. Mulligan, G.L. Mutter and C. Eng, Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast, Am J Pathol 155 (1999), 1253-1260. (Pubitemid 29488932)
19. S. Tsutsui, H. Inoue, K. Yasuda, K. Suzuki, H. Higashi, S. Era and M. Mori, Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast, Oncology 68 (2005), 398-404. (Pubitemid 41160970)
20. X. Yang, Y. Zhang, Y. Huang and F. Yang, Variations in transmembrane Ca2? gradient and apoptosis of macrophages induced by oxidized low density lipoprotein, Biosci Rep 21 (2001), 667-681. (Pubitemid 34816194)
21. S. Eden and H. Cedar, Role of DNA methylation in the regulation of transcription, Curr Opin Genet Dev 4(2) (1994), 255-259. (Pubitemid 24114857)
22. S. Yagi, K. Hirabayashi, S. Sato, W. Li, Y. Takahashi, T. Hi-rakawa et al., DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression, Genome Res 18 (2008), 1969-1978.
23. P.J. Shetty, S. Movva, P. Nagarjuna, V. Bhavani, K.V. Kiran, V. Sambasivan, Y.R. Ahuja and Q. Hasan, Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer, J Cancer Res Clin Oncol, DOI 10.1007/s00432-010-0890-z.
24. A. Murrell, Y. Ito, G. Verde, J. Huddleston, K. Woodfine, M.C. Silengo et al., Distinct Methylation Changes at the IGF2-H19 Locus in Congenital Growth Disorders and Cancer, PLoS ONE 3(3) (2008), e1849.
25. V. Stambolic, D. MacPherson, D. Sas, Y. Lin, B. Snow, Y. Jang, S. Benchimol and T.W. Mak, Regulation of PTEN transcription by p53, Mol Cell 8 (2001), 317-325. (Pubitemid 32831549)
26. H.B. Salvesen, N. MacDonald, A. Ryan, I.J. Jacobs, E.D. Lynch, L.A. Akslen and S. Das, PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma, Int J Cancer 91 (2001), 22-26.
27. Y.E. Wang, X. Wu, H. Suzuki, R.E. Reiter, C. Tran, R. Vessel-la, J.W. Said, B.W. Isaac and C. Sawyers, Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression, Proc Natl Acad Sci USA 95 (1998), 5246-5250. (Pubitemid 28208583)
28. S. Movva, V. Sambasivan, K. Vattam, S. Radha, Y.R. Ahuja and Q. Hasan, Revelance of insulin-like growth factor 2 in the etiopathophysiology of diabetic nephropathy: possible roles of phosphatase and tensin homolog on chromosome 10 and secreted protein acidic and rich in cysteine as regulators of repair, J Diabetes 1 (2009), 118-124.
29. V. Mohan, S. Ponnala, K. Gujjari, P. Boddu, Y.R. Ahuja, Q. Hasan et al., DNA methylation in esophageal diseases including cancer: special reference To hMLH1 gene promoter status, Tumori 92(2) (2006), 155-162. (Pubitemid 43835976)
30. National Cancer Registry Program: Ten year consolidated report of the Hospital Based Cancer Registries, 1984-1993, an assessment of the burden and care of cancer patients, Indian Council of Medical Research, New Delhi, 2001.
31. G. Agarwal, P.V. Pradeep, V. Aggarwal, C.H. Yip and P.S. Cheung, Spectrum of breast cancer in Asian women, Wo r l d J Surg 31 (2007), 1031-1040. (Pubitemid 46716756)
32. R. Chopra, The Indian scene, J Clin Oncol 19(18 SUPPL) (2001), 106S-111S. (Pubitemid 32880092)
33. S.R. Cummings, T. Duong, E. Kenyon, J.A. Cauley, M. White-head and K.A. Krueger, Serum estradiol level and risk of breast cancer during treatment with raloxifene, JAMA 287(2) (2002), 216-220. (Pubitemid 34251947)
34. V. Bhavani, M. Srinivasulu, Y.R. Ahuja and Q. Hasan, Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue, Cancer Biomark 5(4) (2009), 207-213.
35. J. Erickson, Breast Cancer in Cowden Syndrome: Manifestation of a familial cancer syndrome, Clin J Oncol Nurs 14(1) (2010), 33-35.
36. J.I. Risinger, A.K. Hayes, A. Berchuck and J.C. Barrett, PTEN/MMAC1 mutations in endometrial cancers, Cancer Res 57 (1997), 4736-4738. (Pubitemid 27468978)
37. S.H. Chang, S.N. Lee, S.M. Cho, H. Koo, W.S. Han, S.A. Im, I.B. Moon, H.S. Suh, H. Choi and S.H. Sung, Loss of PTEN Expression in breast cancer, The Korean Journal of Pathology 39 (2005), 236-241.
38. D.C. Whiteman, X.P. Shou, M.C. Cummings, S.P. Avey, N.K. Hayward and C. Eng, Nuclear PTEN expression and clini-copathologic features in a population-based series of primary cutaneousmmelanoma, Int J Cancer 99 (2002), 63-67. (Pubitemid 34273199)
39. S.M. Planchon, A.W. Kristin and C. Eng, The nuclear affairs of PTEN, Journal of Cell Science 121 (2007), 249-253. (Pubitemid 351356695)
40. L.S. Rosen, H.L. Ashurst and L. Chap, Targeting Signal Trans-duction Pathways in Metastatic Breast Cancer: A Comprehensive Review, The Oncologist 15(3) (2010), 216-235.
41. E. Rhei, L. Kang, F. Bogomolniy, M.G. Federici, P.I. Bor-gen and J. Boyd, Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas, Cancer Res 57 (1997), 3657-3659. (Pubitemid 27381202)
42. S. Bose, S.I. Wang, M.B. Terry, H. Hibshoosh and R. Parsons, Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas, Oncogene 17 (1998), 123-127. (Pubitemid 28360536)
43. H.E. Feilotter, V. Coulon, J.L. McVeigh, A.H. Boag, F. Dorion-Bonnet, B. Duboue et al., Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma, Br J Cancer 79 (1999), 718-723. (Pubitemid 29082095)
44. M. Esteller, CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future, Oncogene 21 (2002), 5427-5440. (Pubitemid 34983479)
45. V. Sadeq, N. Isar and T. Manoochehr, Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hyperme-thylation, Medical Oncology, DOI 10.1007/s12032-010-9473-8, 2010.
46. H. Wang, M. Karikomi, S. Naidu, R. Rajmohan, E. Caser-ta, H.Z. Chen, M. Rawahneh, J. Moffitt, J.A. Stephens, S.A. Fernandez, M. Weinstein, D. Wang, W. Sadee, K.L. Perle, P. Stromberg, T.J. Rosol, C. Eng, M.C. Ostrowski and G. Leone, Allele-specific tumor spectrum in Pten knockin mice, Proc Natl Acad Sci USA 107(11) (2010), 5142-5147.